Clinical Trial Update: Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating adventitial delivery of temsirolimus to improve below-the-knee angioplasty and/or atherectomy revascularization outcomes in pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Peripheral Artery Disease, Critical Limb Ischemia | Phase 3 | Status: RECRUITING